Wendy Cantrell

1.1k total citations
31 papers, 765 citations indexed

About

Wendy Cantrell is a scholar working on Dermatology, Epidemiology and Immunology. According to data from OpenAlex, Wendy Cantrell has authored 31 papers receiving a total of 765 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Dermatology, 14 papers in Epidemiology and 12 papers in Immunology. Recurrent topics in Wendy Cantrell's work include Nail Diseases and Treatments (12 papers), Psoriasis: Treatment and Pathogenesis (12 papers) and Fungal Infections and Studies (10 papers). Wendy Cantrell is often cited by papers focused on Nail Diseases and Treatments (12 papers), Psoriasis: Treatment and Pathogenesis (12 papers) and Fungal Infections and Studies (10 papers). Wendy Cantrell collaborates with scholars based in United States, United Kingdom and Japan. Wendy Cantrell's co-authors include Boni E. Elewski, Craig A. Elmets, Kenneth J. Smith, Theresa N. Canavan, BE Elewski, Ignasi Pau‐Charles, Diamant Thaçi, M. Falqués, Kristian Reich and Stephen J. Rozzo and has published in prestigious journals such as JNCI Journal of the National Cancer Institute, Journal of the American Academy of Dermatology and British Journal of Dermatology.

In The Last Decade

Wendy Cantrell

29 papers receiving 736 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wendy Cantrell United States 14 325 298 267 120 91 31 765
Mark Lebwohl United States 20 613 1.9× 134 0.4× 787 2.9× 92 0.8× 62 0.7× 44 1.2k
Fabrizio Martora Italy 17 568 1.7× 156 0.5× 365 1.4× 25 0.2× 62 0.7× 85 836
George A. Youngberg United States 15 107 0.3× 136 0.5× 79 0.3× 46 0.4× 64 0.7× 60 719
Warren W. Epinette United States 11 222 0.7× 139 0.5× 269 1.0× 39 0.3× 46 0.5× 17 675
Valerio Brisigotti Italy 17 298 0.9× 136 0.5× 109 0.4× 57 0.5× 20 0.2× 44 632
Shivani B. Kaushik United States 9 407 1.3× 109 0.4× 490 1.8× 14 0.1× 75 0.8× 10 786
M. Lahfa France 15 1.1k 3.3× 145 0.5× 933 3.5× 34 0.3× 174 1.9× 22 1.6k
T.N. Dam Denmark 14 462 1.4× 82 0.3× 753 2.8× 17 0.1× 126 1.4× 21 1.0k
Luca Potestio Italy 25 839 2.6× 219 0.7× 778 2.9× 14 0.1× 207 2.3× 114 1.4k
Gamze Pişkin Netherlands 12 629 1.9× 55 0.2× 979 3.7× 32 0.3× 251 2.8× 17 1.2k

Countries citing papers authored by Wendy Cantrell

Since Specialization
Citations

This map shows the geographic impact of Wendy Cantrell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wendy Cantrell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wendy Cantrell more than expected).

Fields of papers citing papers by Wendy Cantrell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wendy Cantrell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wendy Cantrell. The network helps show where Wendy Cantrell may publish in the future.

Co-authorship network of co-authors of Wendy Cantrell

This figure shows the co-authorship network connecting the top 25 collaborators of Wendy Cantrell. A scholar is included among the top collaborators of Wendy Cantrell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wendy Cantrell. Wendy Cantrell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kircik, Leon, Linda Stein Gold, Joyce Teng, et al.. (2020). Fixed Combination Calcipotriene and Betamethasone Dipropionate (Cal/BD) Foam for Beyond-Mild Psoriasis: A Possible Alternative to Systemic Medication. Journal of Drugs in Dermatology. 19(8). 723–732. 4 indexed citations
2.
Reich, Kristian, Richard B. Warren, Lars Iversen, et al.. (2019). Long‐term efficacy and safety of tildrakizumab for moderate‐to‐severe psoriasis: pooled analyses of two randomized phase III clinical trials (re SURFACE 1 and re SURFACE 2) through 148 weeks. British Journal of Dermatology. 182(3). 605–617. 107 indexed citations
3.
Cantrell, Wendy, et al.. (2019). Treatment of Tinea Capitis. Skin Appendage Disorders. 5(4). 201–210. 34 indexed citations
4.
Tawa, Marianne, et al.. (2019). Cutaneous T-Cell Lymphoma: Optimizing Care in Patients Receiving Anti-CCR4 Monoclonal Antibody Mogamulizumab. Clinical journal of oncology nursing. 23(4). E73–E80. 2 indexed citations
5.
Wang, Casey, Wendy Cantrell, Theresa N. Canavan, & Boni E. Elewski. (2019). Successful Treatment of Dermatophytomas in 19 Patients Using Efinaconazole 10% Solution. Skin Appendage Disorders. 5(5). 304–308. 16 indexed citations
6.
Cantrell, Wendy. (2017). Psoriasis & psoriatic therapies. The Nurse Practitioner. 42(7). 35–39. 1 indexed citations
7.
Canavan, Theresa N., Craig A. Elmets, Wendy Cantrell, John M. Evans, & Boni E. Elewski. (2015). Anti-IL-17 Medications Used in the Treatment of Plaque Psoriasis and Psoriatic Arthritis: A Comprehensive Review. American Journal of Clinical Dermatology. 17(1). 33–47. 51 indexed citations
8.
Canavan, Theresa N., et al.. (2015). An Idiopathic Leukonychia Totalis and Leukonychia Partialis Case Report and Review of the Literature. Skin Appendage Disorders. 1(1). 38–42. 9 indexed citations
9.
Seminario‐Vidal, Lucia, Wendy Cantrell, & Boni E. Elewski. (2015). Pulmonary Cryptococcosis in the Setting of Tofacitinib Therapy for Psoriasis.. PubMed. 14(8). 901–2. 14 indexed citations
10.
Cantrell, Wendy, et al.. (2014). Biologic Agents for Moderate-to-Severe Plaque Psoriasis. Journal of the Dermatology Nurses’ Association. 6(4). 178–196. 1 indexed citations
11.
Cantrell, Wendy, et al.. (2014). Putting onychomycosis under the microscope. The Nurse Practitioner. 39(5). 8–11. 3 indexed citations
12.
Cantrell, Wendy, et al.. (2013). Treatment of onychomycosis using a submillisecond 1064-nm neodymium:yttrium-aluminum-garnet laser. Journal of the American Academy of Dermatology. 69(4). 578–582. 73 indexed citations
13.
DeCoster, Jamie, et al.. (2011). Interest in cosmetic improvement as a marker for tanning behavior: a survey of 1602 respondents. Journal of Cosmetic Dermatology. 10(1). 3–10. 5 indexed citations
14.
Elmets, Craig A., Jaye L. Viner, Alice P. Pentland, et al.. (2010). Chemoprevention of Nonmelanoma Skin Cancer With Celecoxib: A Randomized, Double-Blind, Placebo-Controlled Trial. JNCI Journal of the National Cancer Institute. 102(24). 1835–1844. 167 indexed citations
15.
Cantrell, Wendy, et al.. (2009). Onychomycosis and diabetes. Journal of the European Academy of Dermatology and Venereology. 23(10). 1119–1122. 36 indexed citations
16.
Cantrell, Wendy, et al.. (2008). Diclofenac sodium 3% gel as a potential treatment for disseminated superficial actinic porokeratosis. Journal of the European Academy of Dermatology and Venereology. 23(1). 42–45. 21 indexed citations
17.
Varma, Rajat, Jennifer A. Cafardi, Wendy Cantrell, & Craig A. Elmets. (2008). Safety and Efficacy of Subcutaneously Administered Efalizumab in Adults with Moderate-to-Severe Hand and Foot Psoriasis. American Journal of Clinical Dermatology. 9(2). 105–109. 6 indexed citations
18.
Cafardi, Jennifer A., Wendy Cantrell, Wenquan Wang, Craig A. Elmets, & Boni E. Elewski. (2008). The Safety and Efficacy of High‐Dose Alefacept Compared With a Loading Dose of Alefacept in Patients With Chronic Plaque Psoriasis. SKINmed Dermatology for the Clinician. 7(2). 67–72. 5 indexed citations
19.
Cantrell, Wendy, et al.. (2005). Efficacy of Venous Thromboembolism Prophylaxis in Morbidly Obese Patients Undergoing Gastric Bypass Surgery. Obesity Surgery. 15(9). 1316–1320. 41 indexed citations
20.
Cantrell, Wendy, et al.. (2004). Infliximab therapy for sarcoidosis (lupus pernio). British Journal of Dermatology. 150(1). 146–149. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mark Lebwohl Breakdown of academic impact, for papers by Fabrizio Martora Breakdown of academic impact, for papers by George A. Youngberg Breakdown of academic impact, for papers by Warren W. Epinette Breakdown of academic impact, for papers by Valerio Brisigotti Breakdown of academic impact, for papers by Shivani B. Kaushik Breakdown of academic impact, for papers by M. Lahfa Breakdown of academic impact, for papers by T.N. Dam Breakdown of academic impact, for papers by Luca Potestio Breakdown of academic impact, for papers by Gamze Pişkin
Rankless by CCL
2026